PEG-MGF
Pegylated synthetic variant of IGF-1Ec (Mechano Growth Factor), a muscle-derived IGF-1 splice variant
- Class
- Pegylated splice variant
- Half-life
- ~24–72 hours
- Route
- Intramuscular
- Cadence
- Multiple per week
- Evidence
- Animal data primarily
Overview
PEG-MGF is a pegylated synthetic version of Mechano Growth Factor (MGF), an IGF-1 splice variant your muscles produce in response to mechanical stress or damage. Native MGF lasts only a few minutes in your bloodstream before breaking down, so researchers attached polyethylene glycol (PEG) chains to extend its life to roughly 24–72 hours. The core idea: wake up dormant satellite cells (muscle stem cells) to repair and rebuild damaged muscle tissue faster than your body would on its own.
The biology behind MGF is solid — Geoffrey Goldspink's lab at University College London characterized it in the 1990s and showed that MGF is released locally in muscle after exercise or injury, activating satellite cells to proliferate and fuse into damaged fibers. But PEG-MGF as a marketed product has never been tested in humans. Every study cited by peptide vendors is either cell culture or rodent work. There are no Phase 1 safety trials, no dose-finding studies in people, and no published human pharmacokinetics.
It's sold in research-peptide markets as an intramuscular injection for targeted muscle recovery — the pitch is you inject it into the muscle group you just trained, mimicking the natural MGF pulse your body would produce. The catch: purity and actual peptide content vary wildly between sellers, and there's zero regulatory oversight. You're gambling on whether the vial contains what the label says, let alone whether the PEGylation was done correctly.
Safety considerations
A few of the safety signals worth knowing — the full list, with dosing context and what to monitor, is inside AIx Core.
- Not approved for human use by FDA, EMA, MHRA, or any regulator. Sold as a research chemical with no oversight on purity, sterility, or actual peptide content.
- Prohibited by WADA under S2 (Peptide Hormones, Growth Factors). If you're subject to anti-doping testing, this will flag.
- Zero human safety data. No Phase 1 trials, no toxicology studies in people. The doses circulating in peptide-protocol forums are guesswork extrapolated from rodent studies.
+ 3 more safety notes inside AIx Core →
Commonly monitored
Markers and signals people track when researching PEG-MGF.
- Subjective recovery — post-workout soreness, time to return to training intensity
- Muscle circumference or body composition if using for hypertrophy goals
- Injection site reactions — redness, swelling, prolonged soreness
- Fasting glucose and HbA1c — IGF-1 pathway agonists can affect insulin sensitivity
- Signs of systemic IGF-1 overstimulation — joint pain, carpal tunnel-like symptoms, edema
Frequently asked questions
What is PEG-MGF?
Pegylated synthetic variant of IGF-1Ec (Mechano Growth Factor), a muscle-derived IGF-1 splice variant. PEG-MGF is a pegylated synthetic version of Mechano Growth Factor (MGF), an IGF-1 splice variant your muscles produce in response to mechanical stress or damage. Native MGF lasts only a few minutes in your bloodstream before breaking down, so researchers attached polyethylene glycol (PEG) chains to extend its life to roughly 24–72 hours. The core idea: wake up dormant satellite cells (muscle stem cells) to repair and rebuild damaged muscle tissue faster than your body would on its own.
How is PEG-MGF administered?
Intramuscular, typically multiple per week.
What is the half-life of PEG-MGF?
~24–72 hours — PEGylation extends native MGF half-life from minutes to days — unvalidated in humans.
Is PEG-MGF approved for human use?
PEG-MGF is investigational — not approved by the FDA, EMA, or MHRA for human use at the time of writing.
What does the evidence show for PEG-MGF?
Evidence tier: Animal data primarily. Hill & Goldspink (2003, J Anat) showed native MGF expression spiked within hours of muscle damage in rodents and was associated with satellite cell activation — this is the foundational paper the PEG-MGF pitch is built on, but it didn't test pegylated MGF.
What is commonly monitored when researching PEG-MGF?
Commonly tracked markers + signals: Subjective recovery — post-workout soreness, time to return to training intensity, Muscle circumference or body composition if using for hypertrophy goals, Injection site reactions — redness, swelling, prolonged soreness, Fasting glucose and HbA1c — IGF-1 pathway agonists can affect insulin sensitivity, Signs of systemic IGF-1 overstimulation — joint pain, carpal tunnel-like symptoms, edema.
Related compounds
Open this in AIx Core for the full picture
Mechanism breakdown, receptor pathway diagram, full safety list, monitored items, source citations, and one-tap add-to-protocol. Free with any account.